These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19922111)

  • 1. Ten years of the ALS journal.
    Hardiman O
    Amyotroph Lateral Scler; 2009; 10(5-6):257. PubMed ID: 19922111
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.
    Miller RG; Anderson F; Brooks BR; Mitsumoto H; Bradley WG; Ringel SP;
    Ann Neurol; 2009 Jan; 65 Suppl 1():S24-8. PubMed ID: 19191307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific highlights. 17th International Symposium on ALS/MND Yokohama, Japan, November 30, 2006 through December 2, 2006.
    Sobue G
    Amyotroph Lateral Scler; 2007 Apr; 8(2):121-3. PubMed ID: 17453642
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis.
    Murphy J; Henry R; Lomen-Hoerth C
    Arch Neurol; 2007 Mar; 64(3):330-4. PubMed ID: 17353375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten central themes in a decade of ALS research.
    Rowland LP
    Adv Neurol; 1991; 56():3-23. PubMed ID: 1853764
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis.
    Jusić A; Ries M; Sostarko M
    Neurol Croat; 1992; 41(4):213-26. PubMed ID: 1281433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis.
    Eisen A; Krieger C
    Can J Neurol Sci; 1993 Nov; 20(4):286-96. PubMed ID: 8313244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular therapy in amyotrophic lateral sclerosis].
    Matías-Guiu J; Barcia JA; García-Verdugo JM; Galán L; Vela A; García-Ramos R
    Neurologia; 2008 May; 23(4):226-37. PubMed ID: 18307053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of amyotrophic lateral sclerosis subsets].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S29-4S33. PubMed ID: 17128087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy in amyotrophic lateral sclerosis.
    Distad BJ; Meekins GD; Liou LL; Weiss MD; Carter GT; Miller RG
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):633-51, xi-xii. PubMed ID: 18625421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-year experience with a clinic for amyotrophic lateral sclerosis].
    Aarli JA; Tysnes OB
    Tidsskr Nor Laegeforen; 1997 May; 117(13):1892-5. PubMed ID: 9214008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilaments, free radicals, excitotoxins, and amyotrophic lateral sclerosis.
    al-Chalabi A; Powell JF; Leigh PN
    Muscle Nerve; 1995 May; 18(5):540-5. PubMed ID: 7739643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological health in patients with amyotrophic lateral sclerosis.
    Averill AJ; Kasarskis EJ; Segerstrom SC
    Amyotroph Lateral Scler; 2007 Aug; 8(4):243-54. PubMed ID: 17653923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newsletter for progressive lateral sclerosis patients.
    Levy F
    Muscle Nerve; 1986; 9(3):266. PubMed ID: 3702913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.